Journals / İstanbul Medical Journal / 2015 / Cilt: 16 - Sayı: 4

Siyanoz, Ciltte Spider Anjiyomlar ve Polisitemi ile Başvuran Bir Splenik Marjinal Zon Lenfoma Olgusu

A Splenic Marginal Zone Lymphoma Case Presenting with Cyanosis, Spider Angiomas, and Polycythemia

Pages
158–161
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we report a 43-year-old male hepatitis B virus carrier who presented with abdominal distension, multiple spider angiomas on the skin, and central cyanosis, leading to a diagnosis of SMZL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Splenic marginal zone lymphoma (SMZL) is an indolent cancer classified among low-grade B-cell lymphomas in the World Health Organization (WHO) classification.
📊
Key Findings & Data:The major characteristics of SMZL are splenomegaly, villous cytoplasmic protrusions of the lymphocytes in peripheral blood, anemia, and/or thrombocytopenia.
💡
Conclusion & Impact:Here, we report a 43-year-old male hepatitis B virus carrier who presented with abdominal distension, multiple spider angiomas on the skin, and central cyanosis, leading to a diagnosis of SMZL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Splenic marginal zone lymphoma (SMZL) is an indolent cancer classified among low-grade B-cell lymphomas in the World Health Organization (WHO) classification. The major characteristics of SMZL are splenomegaly, villous cytoplasmic protrusions of the lymphocytes in peripheral blood, anemia, and/or thrombocytopenia. The involvement of various organs, par- ticularly the bone marrow or liver, can be frequently observed. SMZL has been reported to be associated with hepatitis C infection. The course of the disease is generally indolent, but aggressive behavior may be observed in a minority of patients. Here, we report a 43-year-old male hepatitis B virus carrier who presented with abdominal distension, multiple spider angiomas on the skin, and central cyanosis, leading to a diagnosis of SMZL.

Özet

Splenik marjinal zon lenfoma (SMZL) Dünya Sağlık Örgütü sınıflamasın- da B hücreli lenfomalar alt grubunda yer alan yavaş seyirli bir kanserdir. Hastalığa özgü en belirgin klinik ve laboratuar bulguları splenomegali, çevresel kanda villöz uzantılı lenfositler, anemi ve/veya trombositopeni- dir. Kemik iliği ve karaciğer başta olmak üzere çeşitli organ tutulumları görülebilir. SMZL hepatit C virüsü enfeksiyonu ile ilişkilendirilmiştir. Has- talık çoğunlukla yavaş seyretse de küçük bir hasta grubunda agresif gidiş gösterebilir. Burada, 43 yaşında, karında şişkinlik, ciltte yaygın spider form anjiyomlar ve siyanoz ile başvuran splenik marjinal zon lenfoma tanısı konulan hepatit B taşıyıcısı bir olgu sunulmuştur.

🔖

Cite This Article

TÜZÜNER, N., SARIBEYOĞLU, K., AR, M. C., ALTUNOĞLU, E. G. (2022). Siyanoz, Ciltte Spider Anjiyomlar ve Polisitemi ile Başvuran Bir Splenik Marjinal Zon Lenfoma Olgusu. İstanbul Medical Journal, Cilt: 16 - Sayı: 4, 158–161. https://ajindex.com/articles/652061

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds.): Introduction and overview of the classification of the lymphoid neoplasms 157-166, Chapter 8, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Fourth Edition, IARC: Lyon, 2008.
  2. Thieblemont C, Davi F, Briere J, Bertoni F, Zucca E, Traverse-Glehen A, et al. Splenic marginal zone lymphoma: current knowledge and future directions. Oncology 2012; 26: 194-202.
  3. Luca Arcaini, Paulli M. Splenic marginal zone lymphoma: hydra with many heads? Haematologica 2010; 95: 534-7. [CrossRef] Yang SM, Jiang Q, Jiang B, Chen DB, Wang J, Jiang H, et al. Clinical characteristics of splenic marginal zone lymphoma with abnormal complete blood count. Zhongguo Shi Yan Xue Ye XueZaZhi 2013; 21: 87-94.
  4. Dogan A, Isaacson PG. Splenic marginal zone lymphoma. Semin Di- agn Pathol 2003; 20: 121-7. [CrossRef] Barışta İ. Folliküler lenfoma, ekstranodal marjinal zon lenfoması, nodal marjinal zon lenfoma, splenik marjinal zon Lenfoma, lenfop- lazmasitik lenfoma.Türk Hematoloji Derneği Klinisyen Patolog Ortak Lenfoma Kursu Eğitim Kitapçığı (Education Book), 2004: 47-53.
  5. Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood 2003; 101: 2464-72. [CrossRef] Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocy- tes/splenic marginal zone lymphoma. Semin Hematol 1999; 36: 148-54.
  6. Kaygusuz G, Kuzu I. Recent advances in diagnosis, prognosis and bio- logy of small B cell lymphomas. Turk J Hematol 2006; 23: 173-81.
  7. Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pat- hol 2007; 60: 1378-83. [CrossRef] Yu SC, Lin CW. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection. Kaohsiung J Med Sci 2013; 29: 150-6. [CrossRef] Carr JA. Splenic marginal zone lymphoma masquerading as cirrhotic hypersplenism for seven years. Can J Gastroenterol 2012; 26: 123-4.
  8. Vladareanu AM, Onisai M, Ciufu C, BumbeaH,Cisleanu D, Voican I, et al. Splenectomy -a therapeutic option in splenic marginal zone cell lymphoma. Rom J Intern Med 2009; 47: 191-9.
  9. Joshi M, Sheikh H, Abbi K, Long S, Sharma K, Tuchinky M, et al. Margi- nal zone lymphoma: old, targeted and epigenetic therapies. Ther Adv Hematol 2012; 3: 275-90. [CrossRef]